Scott Bryson

564 total citations
19 papers, 396 citations indexed

About

Scott Bryson is a scholar working on Pharmacology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Scott Bryson has authored 19 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 3 papers in Molecular Biology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Scott Bryson's work include Antibiotics Pharmacokinetics and Efficacy (4 papers), Poisoning and overdose treatments (3 papers) and Metabolism and Genetic Disorders (2 papers). Scott Bryson is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (4 papers), Poisoning and overdose treatments (3 papers) and Metabolism and Genetic Disorders (2 papers). Scott Bryson collaborates with scholars based in United Kingdom, Canada and United States. Scott Bryson's co-authors include B. Whiting, A. W. Kelman, Michael A. McGuigan, Alison H. Thomson, Melissa Givens, Alexander B. Mullen, Jake J. Thiessen, Mark Greenberg, Andrew W. Kelman and J. Anthony Brandon and has published in prestigious journals such as The Journal of Pediatrics, Journal of Antimicrobial Chemotherapy and British Journal of Clinical Pharmacology.

In The Last Decade

Scott Bryson

18 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Scott Bryson United Kingdom	11	131	70	66	64	55	19	396
Uwe Tröger Germany	12	144 1.1×	68 1.0×	52 0.8×	48 0.8×	46 0.8×	29	426
David F. Lehmann United States	13	166 1.3×	67 1.0×	59 0.9×	57 0.9×	48 0.9×	37	464
Brian G. Hardy Canada	12	153 1.2×	50 0.7×	46 0.7×	134 2.1×	26 0.5×	15	522
Régis Bouquié France	14	171 1.3×	67 1.0×	110 1.7×	67 1.0×	72 1.3×	33	498
Phillip Paull Australia	11	104 0.8×	49 0.7×	32 0.5×	39 0.6×	33 0.6×	20	377
Adrienne Smith United States	10	83 0.6×	51 0.7×	99 1.5×	58 0.9×	37 0.7×	22	530
Mia Parsonnet United States	7	197 1.5×	67 1.0×	58 0.9×	54 0.8×	25 0.5×	11	397
Mike West United Kingdom	9	132 1.0×	156 2.2×	73 1.1×	101 1.6×	163 3.0×	9	538
V. Malerczyk Germany	15	262 2.0×	71 1.0×	79 1.2×	73 1.1×	66 1.2×	46	575
Susan Willavize United States	14	232 1.8×	183 2.6×	64 1.0×	94 1.5×	55 1.0×	31	653

Countries citing papers authored by Scott Bryson

Since Specialization

Citations

This map shows the geographic impact of Scott Bryson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Bryson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Bryson more than expected).

Fields of papers citing papers by Scott Bryson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Bryson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Bryson. The network helps show where Scott Bryson may publish in the future.

Co-authorship network of co-authors of Scott Bryson

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Bryson. A scholar is included among the top collaborators of Scott Bryson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Bryson. Scott Bryson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Morrison, Ian, et al.. (2023). Iatrogenic copper deficiency: Risks and cautions with zinc prescribing. British Journal of Clinical Pharmacology. 89(9). 2825–2829. 3 indexed citations

Bustami, Rami, et al.. (2022). Awareness and attitudes of oncology specialists toward dihydropyrimidine dehydrogenase testing in Saudi Arabia. Cancer Reports. 6(2). e1704–e1704. 1 indexed citations

Kavanagh, Kimberley, Jiafeng Pan, Charis Marwick, et al.. (2016). Cumulative and temporal associations between antimicrobial prescribing and community-associatedClostridium difficileinfection: population-based case–control study using administrative data. Journal of Antimicrobial Chemotherapy. 72(4). dkw528–dkw528. 17 indexed citations

Mullen, Alexander B., et al.. (2013). Antibiotic treatment of urinary tract infection by community pharmacists: a cross-sectional study. British Journal of General Practice. 63(609). e244–e249. 41 indexed citations

Zhao, Yanming, Ravshan Burikhanov, J. Anthony Brandon, et al.. (2011). Systemic Par-4 inhibits non-autochthonous tumor growth. Cancer Biology & Therapy. 12(2). 152–157. 25 indexed citations

Givens, Melissa, et al.. (2008). Comparison of methanol exposure routes reported to Texas poison control centers.. PubMed. 9(3). 150–3. 20 indexed citations

Hair, Amy B., et al.. (2001). Pharmaceutical care needs of patients with angina.. Pharmacy World & Science. 23(5). 175–176. 6 indexed citations

Bryson, Scott, et al.. (1995). The Effects of Age And Chemotherapy on Gentamicin Pharmacokinetics and Dosing in Pediatric Oncology Patients. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 15(6). 754–764. 19 indexed citations

Thiessen, Jake J., et al.. (1994). Challenges in Comparing Treatment Outcome from a Prospective with That of a Retrospective Study. Therapeutic Drug Monitoring. 16(3). 238–247. 9 indexed citations

10.

Eisenstat, David D., et al.. (1991). Amantadine Neurotoxicity in a Pediatric Patient with Renal Insufficiency. DICP. 25(11). 1175–1177. 9 indexed citations

11.

Koren, Gideon, et al.. (1990). Interaction between digoxin and propafenone in children. The Journal of Pediatrics. 116(2). 310–312. 10 indexed citations

12.

Bryson, Scott, et al.. (1989). Therapeutic Monitoring of Cyclosporine following Pediatric Bone Marrow Transplantation: Problems with Sampling from Silicone Central Venous Lines. DICP. 23(4). 300–303. 13 indexed citations

13.

Bryson, Scott, et al.. (1988). Population Pharmacokinetics of Gentamicin in Neonates. Developmental Pharmacology and Therapeutics. 11(3). 173–179. 49 indexed citations

14.

McGuigan, Michael A., et al.. (1988). Caffeine Overdose in an Adolescent Male. Journal of Toxicology Clinical Toxicology. 26(5-6). 407–415. 23 indexed citations

15.

Bryson, Scott. (1983). Clinical Pharmacokinetics: Concepts and applications.. Journal of Clinical Pharmacy and Therapeutics. 8(1). 87–88. 125 indexed citations

16.

Bryson, Scott, et al.. (1982). The influence of protein binding on disopyramide clearance. European Journal of Clinical Pharmacology. 23(5). 453–456. 12 indexed citations

17.

Bryson, Scott, et al.. (1982). COMPARISON OF A HIGH PRESSURE LIQUID CHROMATOGRAPHIC ANALYSIS AND AN ENZYME IMMUNOASSAY TECHNIQUE FOR QUANTITATION OF DISOPYRAMIDE IN SERUM OR PLASMA. Journal of Clinical Pharmacy and Therapeutics. 7(2). 119–126. 1 indexed citations

18.

Kelman, Andrew W., B. Whiting, & Scott Bryson. (1982). Parameter optimisation in clinical pharmacokinetics. Computer Programs in Biomedicine. 14(3). 239–248. 13 indexed citations

19.

Vansina, Jan, et al.. (1981). Arts traditionnels et histoire au Zaïre : cultures forestières et royaumes de la savane. Medical Entomology and Zoology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact